Celator Pharmaceuticals
Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1...Homepage: http://www.celatorpharma.com/
Total money raised: $59.3M
08540
303B College Road East
Princeton
USA NJ
Princeton
USA NJ
Phone: (609) 243-0123
Updated on May 6, 2013
Celator Pharmaceuticals at CrunchBase
Scott Jackson CEOCelator Pharmaceuticals at CrunchBase
Nicole Vitullo Board Member
Past
April, 2013
Celator Pharmaceuticals raised $39.3M in private_equity round from ROTH Capital Partners and Valence Life Sciences
CELATOR® PHARMACEUTICALS RAISES $32.5 MILLION COMPLETING A $39.3 MILLION PRIVATE PLACEMENT FINANCING 
celatorpharma.com
September, 2010
Celator Pharmaceuticals raised $20M in a Series D round from Thomas, McNerney & Partners, Domain Associates, Ventures West, Quaker BioVentures, TL Ventures, GrowthWorks Capital, and BDC Venture Capital
CELATOR® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING celatorpharma.com